Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H4 | Q96RI1 | 20/20 | 0.53 |
| ▸ | ESR1 | P03372 | 1/20 | 0.51 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.51 |
| ▸ | PGR | P06401 | 1/20 | 0.51 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.51 |
| ▸ | AR | P10275 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4517695 | 0.91 | NR1H4 (0.65) | NR1H4ESR1NR3C1PGRNR3C2 | |
| SCHEMBL4532904 | 0.91 | NR1H4 (0.65) | NR1H4ESR1NR3C1PGRNR3C2 | |
| SCHEMBL4528591 | 0.86 | NR1H4 (0.56) | NR1H4ESR1NR3C1PGRNR3C2 | |
| SCHEMBL4527816 | 0.85 | NR1H4 (0.38) | NR1H4ESR1NR3C1PGRNR3C2 | |
| SCHEMBL4532907 | 0.85 | NR1H4 (0.39) | NR1H4ESR1NR3C1PGRNR3C2 | |
| SCHEMBL4297026 | 0.82 | NR1H4 (0.72) | NR1H4ESR1NR3C1PGRNR3C2 | |
| SCHEMBL4536906 | 0.80 | NR1H4 (0.67) | NR1H4ESR1NR3C1PGRNR3C2 | |
| SCHEMBL13756335 | 0.80 | NR1H4 (0.47) | NR1H4ESR1NR3C1PGRNR3C2 | |
| SCHEMBL4299618 | 0.80 | NR1H4 (0.73) | NR1H4ESR1NR3C1PGRNR3C2 | |
| SCHEMBL4529422 | 0.79 | NR1H4 (0.65) | NR1H4ESR1NR3C1PGRNR3C2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1963331-A1 | AZEPINOINDOLE DERIVATIVES AS PHARMACEUTICAL AGENTS | Exelixis, Inc. (US) | 2008-09-03 | — | — | EP | disclosed |
| WO-2007070796-A1 | AZEPINOINDOLE DERIVATIVES AS PHARMACEUTICAL AGENTS | EXELIXIS, INC. (US) | 2007-06-21 | — | — | WO | disclosed |